Sophie A. Valkenburg

3.8k total citations · 2 hit papers
62 papers, 2.3k citations indexed

About

Sophie A. Valkenburg is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Sophie A. Valkenburg has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 36 papers in Immunology and 19 papers in Infectious Diseases. Recurrent topics in Sophie A. Valkenburg's work include Influenza Virus Research Studies (35 papers), Immune Cell Function and Interaction (21 papers) and Respiratory viral infections research (18 papers). Sophie A. Valkenburg is often cited by papers focused on Influenza Virus Research Studies (35 papers), Immune Cell Function and Interaction (21 papers) and Respiratory viral infections research (18 papers). Sophie A. Valkenburg collaborates with scholars based in Hong Kong, Australia and United States. Sophie A. Valkenburg's co-authors include Katherine Kedzierska, Peter C. Doherty, Malik Peiris, Leo L. M. Poon, Stephen T. Turner, Benjamin J. Cowling, Paul G. Thomas, Asmaa Hachim, Stéphanie Gras and Alex W. H. Chin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Sophie A. Valkenburg

60 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

2022 144 citations Sheena G. Sullivan, Sophie A. Valkenburg et al. Nature Communications profile →
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

2023 116 citations Samuel M. S. Cheng, Kathy Leung et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophie A. Valkenburg Hong Kong	26	1.1k	1.0k	801	518	121	62	2.3k
Ali H. Ellebedy United States	27	1.5k 1.3×	1.5k 1.5×	1.8k 2.3×	1.0k 2.0×	264 2.2×	66	3.9k
Meagan McMahon United States	20	694 0.6×	452 0.4×	1.4k 1.8×	408 0.8×	162 1.3×	36	2.2k
Cheryl Cameron United States	24	870 0.8×	740 0.7×	665 0.8×	427 0.8×	40 0.3×	46	2.2k
Shirin Strohmeier United States	21	757 0.7×	525 0.5×	1.5k 1.9×	328 0.6×	162 1.3×	44	2.3k
Daniel Stadlbauer United States	18	733 0.7×	422 0.4×	1.4k 1.7×	285 0.6×	173 1.4×	31	2.1k
Min Wu China	23	1.2k 1.0×	485 0.5×	825 1.0×	859 1.7×	28 0.2×	63	2.5k
Adrian B. McDermott United States	33	1.3k 1.1×	1.7k 1.7×	843 1.1×	680 1.3×	302 2.5×	84	3.3k
Xiao‐Ning Xu United Kingdom	30	576 0.5×	1.3k 1.3×	1.2k 1.5×	523 1.0×	56 0.5×	55	3.1k
Paul‐Henri Lambert Switzerland	22	612 0.5×	938 0.9×	557 0.7×	337 0.7×	101 0.8×	32	1.9k
Xiao-Ning Xu United Kingdom	7	679 0.6×	853 0.8×	676 0.8×	371 0.7×	34 0.3×	7	1.7k

Countries citing papers authored by Sophie A. Valkenburg

Since Specialization

Citations

This map shows the geographic impact of Sophie A. Valkenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie A. Valkenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie A. Valkenburg more than expected).

Fields of papers citing papers by Sophie A. Valkenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie A. Valkenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie A. Valkenburg. The network helps show where Sophie A. Valkenburg may publish in the future.

Co-authorship network of co-authors of Sophie A. Valkenburg

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie A. Valkenburg. A scholar is included among the top collaborators of Sophie A. Valkenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie A. Valkenburg. Sophie A. Valkenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fox, Annette, Louise Carolan, Yuyun Chen, et al.. (2025). Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist. Clinical Infectious Diseases. 81(4). e192–e201. 2 indexed citations

Cohen, Carolyn A., Haogao Gu, Raghavan Varadarajan, et al.. (2024). Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children. Nature Communications. 15(1). 3210–3210. 1 indexed citations

Cohen, Carolyn A., Nancy Leung, Prathanporn Kaewpreedee, et al.. (2024). Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2. Nature Communications. 15(1). 7358–7358. 3 indexed citations

Cheng, Samuel M. S., Kathy Leung, Cheuk Kwong Lee, et al.. (2023). Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity. Journal of Clinical Virology. 170. 105621–105621. 3 indexed citations

Tan, Tiong Kit, Yi‐Mo Deng, Sophie A. Valkenburg, et al.. (2023). Single-cycle influenza virus vaccine generates lung CD8 ⁺ Trm that cross-react against viral variants and subvert virus escape mutants. Science Advances. 9(36). eadg3469–eadg3469. 10 indexed citations

Cheng, Samuel M. S., Kathy Leung, Cheuk Kwong Lee, et al.. (2023). Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nature Medicine. 29(2). 348–357. 116 indexed citations breakdown →

Tan, Chee Wah, Samuel M. S. Cheng, Haogao Gu, et al.. (2022). Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses. Nature Communications. 13(1). 6285–6285. 3 indexed citations

Mok, Chris Ka Pun, Carolyn A. Cohen, Samuel M. S. Cheng, et al.. (2021). Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong. Respirology. 27(4). 301–310. 91 indexed citations

Bull, Maireid, Carolyn A. Cohen, Nancy Leung, & Sophie A. Valkenburg. (2021). Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread. Viruses. 13(9). 1779–1779. 4 indexed citations

10.

Cohen, Carolyn A., Nancy Leung, Vicky J. Fang, et al.. (2021). Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults. npj Vaccines. 6(1). 25–25. 44 indexed citations

11.

Nguyen, Thi H. O., Carolyn A. Cohen, Louise C. Rowntree, et al.. (2021). T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants. Frontiers in Medicine. 8. 793102–793102. 14 indexed citations

12.

Kavian, Niloufar, Asmaa Hachim, Carolyn A. Cohen, et al.. (2020). Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults. Clinical & Translational Immunology. 9(2). e1107–e1107. 16 indexed citations

13.

Biquand, Élise, Raquel Muñoz-Moreno, Chris Mok, et al.. (2020). OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1. Cell Reports. 30(5). 1570–1584.e6. 51 indexed citations

14.

Valkenburg, Sophie A., Vicky J. Fang, Nancy Leung, et al.. (2019). Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission. Clinical & Translational Immunology. 8(11). e1092–e1092. 8 indexed citations

15.

Clemens, E. Bridie, Carolien E. van de Sandt, Sook‐San Wong, Linda M. Wakim, & Sophie A. Valkenburg. (2018). Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. Vaccines. 6(2). 18–18. 88 indexed citations

16.

Valkenburg, Sophie A., et al.. (2016). Preexisting Antibody-Dependent Cellular Cytotoxicity–Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure. The Journal of Infectious Diseases. 214(8). 1159–1163. 7 indexed citations

17.

Grant, Emma J., Tracy M. Josephs, Sophie A. Valkenburg, et al.. (2016). Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures. Journal of Biological Chemistry. 291(47). 24335–24351. 19 indexed citations

18.

Loh, Liyen, et al.. (2014). Universal immunity to influenza must outwit immune evasion. Frontiers in Microbiology. 5. 285–285. 43 indexed citations

19.

Kedzierska, Katherine, Joan Curtis, Sophie A. Valkenburg, et al.. (2012). Induction of Protective CD4+ T Cell-Mediated Immunity by a Leishmania Peptide Delivered in Recombinant Influenza Viruses. PLoS ONE. 7(3). e33161–e33161. 20 indexed citations

20.

Kedzierska, Katherine, Sophie A. Valkenburg, Carole Guillonneau, et al.. (2009). Diversity and clonotypic composition of influenza‐specific CD8⁺ TCR repertoires remain unaltered in the absence of Aire. European Journal of Immunology. 40(3). 849–858. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact